Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...
When six infants around the world were diagnosed with an odd trio of symptoms (diabetes, epilepsy, and abnormally small heads ...
A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels ...
Two days after Intellia voluntarily paused dosing due to safety concerns, the regulator stepped in with an official hold that ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
ZUG, Switzerland and BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...
Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback